What is Henry Schein's market cap?

Henry Schein (HSIC) has a market capitalization of $9.41B as of June 15, 2026. Market cap is the total market value of the company's outstanding shares (share price × shares outstanding), shown here in US dollars (USD).

How is Henry Schein's market cap calculated, and what currency is it in?

Market capitalization is calculated by multiplying Henry Schein's share price by its total shares outstanding. Although Henry Schein reports its financial statements in USD, market cap on this page is shown in US dollars (USD) for comparability with other companies.

What is the highest market cap Henry Schein has reached?

Henry Schein (HSIC) reached its all-time high market cap of $12.90B on April 13, 2022, based on daily closing values in our history.

What is the lowest market cap Henry Schein has reached?

Henry Schein (HSIC) recorded its all-time low market cap of $1.23B on February 14, 2003 in the available daily history.

Is Henry Schein's market cap above or below its 5-year average?

At $9.41B, Henry Schein's market cap is currently below its five-year average of $9.87B.

What was Henry Schein's market cap in 2025?

Henry Schein (HSIC) ended 2025 with a market cap of $9.27B.

What was Henry Schein's market cap in 2026?

Henry Schein (HSIC) ended 2026 with a market cap of $9.41B.

Henry Schein (HSIC) Market Cap History

Current

$9.41B

As of Jun 15, 2026

5-Year Average

$9.87B

All-Time High

$12.90B

Apr 13, 2022

All-Time Low

$1.23B

Feb 14, 2003

Market cap daily chart for Henry Schein (HSIC)

Jun 16, 2021 – Jun 15, 2026 · 1,255 trading days

Market Cap growth chart for Henry Schein (HSIC) from 1995 to 2026

Latest: +1.6%

Market Cap history table for Henry Schein (HSIC) from 1995 to 2026


2026	$9.41B	+1.6%	+$145.02M	Jun 15, 2026	May 5, 2026
2025	$9.27B	+3.0%	+$268.17M	Dec 27, 2025	Feb 24, 2026
2024	$9.00B	-9.8%	−$976.44M	Dec 28, 2024	Feb 25, 2025
2023	$9.97B	-9.3%	−$1.03B	Dec 31, 2023	Feb 28, 2024
2022	$11.00B	+0.1%	+$10.88M	Dec 31, 2022	Feb 21, 2023
2021	$10.99B	+14.6%	+$1.40B	Dec 31, 2021	Feb 15, 2022
2020	$9.59B	-3.7%	−$370.44M	Dec 31, 2020	Feb 17, 2021
2019	$9.96B	+5.2%	+$492.49M	Dec 31, 2019	Feb 20, 2020
2018	$9.47B	+9.2%	+$794.91M	Dec 31, 2018	Feb 20, 2019
2017	$8.67B	-10.2%	−$989.68M	Dec 31, 2017	Dec 31, 2017
2016	$9.66B	-7.4%	−$776.73M	Dec 31, 2016	Feb 21, 2017
2015	$10.44B	+14.0%	+$1.28B	Dec 31, 2015	Feb 10, 2016
2014	$9.16B	+16.6%	+$1.30B	Dec 31, 2014	Feb 11, 2015
2013	$7.85B	+38.6%	+$2.19B	Dec 31, 2013	Feb 11, 2014
2012	$5.67B	+21.0%	+$985.16M	Dec 31, 2012	Feb 13, 2013
2011	$4.68B	+4.2%	+$189.62M	Dec 31, 2011	Feb 15, 2012
2010	$4.49B	+20.2%	+$754.86M	Dec 31, 2010	Feb 22, 2011
2009	$3.74B	+42.3%	+$1.11B	Dec 31, 2009	Feb 23, 2010
2008	$2.63B	-40.2%	−$1.77B	Dec 31, 2008	Feb 24, 2009
2007	$4.39B	+27.2%	+$939.63M	Dec 31, 2007	Feb 26, 2008
2006	$3.45B	+13.9%	+$421.74M	Dec 31, 2006	Feb 28, 2007
2005	$3.03B	+24.0%	+$585.59M	Dec 31, 2005	Mar 10, 2006
2004	$2.44B	+2.6%	+$61.96M	Dec 31, 2004	Mar 11, 2005
2003	$2.38B	+50.5%	+$799.18M	Dec 31, 2003	Mar 9, 2004
2002	$1.58B	-37.5%	−$947.33M	Dec 31, 2002	Mar 24, 2003
2001	$2.53B	+9.3%	+$214.33M	Dec 31, 2001	Mar 19, 2002
2000	$2.32B	-29.3%	−$959.14M	Dec 31, 2000	Mar 28, 2001
1999	$3.27B	-70.3%	−$7.73B	Dec 31, 1999	Mar 24, 2000
1998	$11.01B	+27.9%	+$2.40B	Dec 31, 1998	Mar 16, 1999
1997	$8.61B	+1.8%	+$153.72M	Dec 31, 1997	Apr 24, 1998
1996	$8.45B	+16.5%	+$1.20B	Dec 31, 1996	Jun 27, 1997
1995	$7.26B	—	—	Dec 31, 1995	Dec 31, 1995

2026$9.41B+1.6%
2025$9.27B+3.0%
2024$9.00B-9.8%
2023$9.97B-9.3%
2022$11.00B+0.1%
2021$10.99B+14.6%
2020$9.59B-3.7%
2019$9.96B+5.2%
2018$9.47B+9.2%
2017$8.67B-10.2%
2016$9.66B-7.4%
2015$10.44B+14.0%
2014$9.16B+16.6%
2013$7.85B+38.6%
2012$5.67B+21.0%
2011$4.68B+4.2%
2010$4.49B+20.2%
2009$3.74B+42.3%
2008$2.63B-40.2%
2007$4.39B+27.2%
2006$3.45B+13.9%
2005$3.03B+24.0%
2004$2.44B+2.6%
2003$2.38B+50.5%
2002$1.58B-37.5%
2001$2.53B+9.3%
2000$2.32B-29.3%
1999$3.27B-70.3%
1998$11.01B+27.9%
1997$8.61B+1.8%
1996$8.45B+16.5%
1995$7.26B—

Market Cap values are taken from Henry Schein's reported income statements (share counts) and end-of-day prices (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About Market Cap at Henry Schein (HSIC)

According to Henry Schein's latest reported financial statements, the company's latest reported market cap is $8.37B. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).

Headline figure above is from the reporting period ending March 28, 2026 (reported May 5, 2026). Chart and table below cover the full reported history back to 1995.

Henry Schein (HSIC) most recent annual market cap stands at $9.41B (2026) – edged up 1.6% year-over-year.

Looking at the 2021–2026 (5 years) stretch, Henry Schein market cap compounded at -3.1% per year, sustaining 2 straight years of year-over-year growth.

Henry Schein market cap declined from $11.01B in 1998 to $9.41B in 2026, a 14.5% drawdown.

$11.01B stands as the all-time-high annual market cap, posted in 1998, against a low of $1.58B during 2002.

Henry Schein Market Cap by Year

Henry Schein Market Cap 2026: $9.41B

In 2026, Henry Schein reported market cap of $9.41B, edged up 1.6% from 2025.

Henry Schein Market Cap 2025: $9.27B

Henry Schein market cap in 2025 was $9.27B, edged up 3.0% from 2024.

Henry Schein Market Cap 2024: $9.00B

2024's market cap for Henry Schein came in at $9.00B, declined 9.8% below 2023.

Henry Schein Market Cap 2023: $9.97B

Henry Schein posted market cap of $9.97B in 2023, declined 9.3% below 2022.

Henry Schein Market Cap 2022: $11.00B

Henry Schein market cap in 2022 was $11.00B.

See more financial history for Henry Schein (HSIC).

Sector peers by Market Cap

Healthcare peers of Henry Schein (HSIC), ranked by their latest market cap


Eli Lilly (LLY)	$1.06T
Johnson & Johnson (JNJ)	$567.28B
AbbVie (ABBV)	$391.50B
UnitedHealth Group (UNH)	$373.28B
Merck & Co. (MRK)	$283.78B
AstraZeneca (AZN)	$274.92B
Novo Nordisk (NVO)	$195.17B
Amgen (AMGN)	$189.18B

Frequently asked questions

Henry Schein (HSIC) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Overview

HSIC Overview

Counters

Income Statement

Cash Flow

Capital Return

Forecast & Valuation